MYD88 and asthma: In the context of asthma, dysregulation or aberrant activation of the MyD88-dependent signaling pathway has been implicated in the development of immune imbalance, characterized by enhanced type 2 immune responses, suppression of regulatory T cell function, and exacerbated airway inflammation and remodeling.